AC
CLBT icon

Armistice Capital’s Cellebrite CLBT Stock Holding History

Armistice Capital’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,759
Closed -$302K – 302
2025
Q4 		$302K Buy
+16,759
New +$301K ﹤0.01% 243
2024
Q2 		– Sell
-16,618
Closed -$184K – 282
2024
Q1 		$184K Buy
+16,618
New +$170K ﹤0.01% 296

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital's CLBT Position: Q1 2026 in Review

Armistice Capital sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 16,759 shares — an estimated $302K sold.

Armistice Capital first reported a position in CLBT in Q1 2024 and held it in 2 quarters. The position peaked at $302K in Q4 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Armistice Capital reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 16,759 Cellebrite shares in Q1 2026, an estimated $302K.
  • Armistice Capital first reported a position in Cellebrite in Q1 2024 and held it in 2 quarters.
  • Armistice Capital's Cellebrite position peaked at $302K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.